Neuberger Berman High Yield Strategies SEC Filings

NHS NYSE

Welcome to our dedicated page for Neuberger Berman High Yield Strategies SEC filings (Ticker: NHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Wondering whether Neuberger Berman High Yield Strategies Fund (NHS) can keep covering its monthly payout? Most investors start with the annual report yet soon discover page after page of credit tables and leverage footnotes. Our platform answers those questions in minutes.

Use Stock Titan to jump straight to what matters in every NHS filing. From the N-CSR that details distribution coverage to the 8-K material events explained, our AI-powered summaries translate technical language into plain English. You’ll see credit-rating shifts, leverage-cost trends and portfolio turnover without reading the entire document.

Need the latest moves by portfolio managers? The Neuberger Berman High Yield Strategies Fund insider trading Form 4 transactions feed shows executive stock trades as they hit EDGAR. Curious about quarterly results? The NHS quarterly earnings report 10-Q filing is parsed instantly, highlighting net investment income and unrealized gains. Our coverage spans every form:

NHS executive stock transactions Form 4 (real-time alerts)
NHS annual report 10-K simplified with AI commentary
Current reports—NHS 8-K material events explained
Proxy statement for NHS executive compensation

Each document arrives on Stock Titan seconds after EDGAR posts. Our expert analysis layers context, compares past periods and flags red-line changes. Whether you’re monitoring high-yield credit exposure, tracking distribution sustainability, or simply looking for understanding NHS SEC documents with AI, this is your single stop.

06/24/2025 10:54 AM

Filing

[NPORT-P] Neuberger Berman High Yield Strategies Fund Inc. SEC Filing

Rhea-AI Summary

Neuberger Berman High Yield Strategies Fund (NYSE:NHS) submitted a routine monthly Form NPORT-P on 29 June 2025. The public version lists required data fields—assets, liabilities, risk metrics (DV01/DV100, credit-spread exposure), securities-lending activity, monthly fund returns, and share flows—but most numeric details are either redacted or reported at the individual-security level. No narrative, risk factors, legal proceedings, or management commentary accompany the filing, and no aggregate financial highlights are provided.

Because NPORT-P reports are primarily informational and the disclosed figures are limited, this filing does not reveal any material changes to NHS’s strategy, leverage, or financial condition that would meaningfully affect investor sentiment.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Neuberger Berman High Yield Strategies (NHS)?

The current stock price of Neuberger Berman High Yield Strategies (NHS) is $7.58 as of June 30, 2025.

What is the market cap of Neuberger Berman High Yield Strategies (NHS)?

The market cap of Neuberger Berman High Yield Strategies (NHS) is approximately 224.2M.

What is Neuberger Berman High Yield Strategies Fund?

It is a closed-end investment company that focuses on investing in high yield debt securities from U.S. and international issuers. It is managed by Neuberger Berman, a renowned independent, employee-owned investment manager.

What type of investments does the fund primarily focus on?

The fund primarily invests in high yield debt securities, aiming to generate consistent income through a diversified portfolio of lower-rated bonds and similar debt instruments.

How does the fund generate income?

Income is generated through a blend of net investment income, realized capital gains, and return of capital. This mix allows the fund to maintain regular distributions under normal market conditions.

What role does active management play in the fund’s strategy?

Active management is central to the fund's strategy. The team conducts rigorous research and continuous monitoring to select appropriate high yield opportunities and adjust the portfolio as market conditions change.

How does the fund maintain stability in its distribution policy?

The fund employs a disciplined investment strategy and diversified income sources to strive for stable monthly distributions. This approach involves offsetting market volatility through strategic asset selection and risk management.

How is the fund affiliated with Neuberger Berman?

The fund is managed by Neuberger Berman, an employee-owned, independent investment manager with a lengthy history of active management and a broad range of investment strategies across global markets.

How does the fund differentiate itself from other closed-end funds?

The fund differentiates itself through its strong emphasis on active management, rigorous research, and diversified income strategies, underpinned by the extensive expertise of Neuberger Berman.

What should investors know about the fund's risk management?

Investors should note that the fund employs detailed risk assessments and dynamic portfolio adjustments to mitigate market volatility, reflecting a sophisticated approach to managing credit and market risks.